RobertMichaelEagerMD

Internal Medicine • Federal Way, WA

Physician

Join to view full profile

Dr. Eager is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Eager's full profile

Already have an account?

Office
34503 9th Ave
Ste 100
Federal Way, WA 98003
Phone+1 253-835-8700

Fax+1 253-835-8755
Is this information wrong?

Education & Training

University of HawaiiResidency, Internal Medicine, 2007 - 2010
University of Texas Medical Branch School of MedicineClass of 2007

Certifications & Licensure

WA State Medical License 2011 - 2026
HI State Medical License 2007 - 2022
TX State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016

Publications & Presentations

PubMed

65 citations
Cardio-oncology/onco-cardiology.
Robert Hong, Takeshi Iimura, Kenneth N. Sumida, Robert M. Eager> ;Clinical Cardiology. 2010 Dec 1
64 citations
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
Robert M Eager, Casey Cunningham, Neil Senzer, Joe Stephenson, Stephen P. Anthony, Steven J. O'Day, G. Frenette, Anna C. Pavlick, Barry Jones, Margaret J. Uprichard, J...> ;BMC Cancer. 2009 Jul 30
43 citations
Ad-MDA-7; INGN 241: a review of preclinical and clinical experience.
Robert M Eager, Lindsey Harle, John Nemunaitis> ;Expert Opinion on Biological Therapy. 2008 Sep 7
15 citations
Aggressive juvenile fibromatosis of the paranasal sinuses: case report and brief review.
Shaheen E Lakhan, Robert M Eager, Lindsey Harle> ;Journal of Hematology & Oncology. 2008 May 28
85 citations
GM-CSF gene-transduced tumor vaccines.
Robert Eager, John Nemunaitis> ;Molecular Therapy. 2005 Jul 1
Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancer.
Nemunaitis, J. J., Orr, D., Eager, R., Cunningham, C. C., Williams, A., Mennel, R., Grove, W., Olson, S.> ;Cancer J. 2003 Jan 01
Clinical development directions in oncolytic viral therapy.
Eager, R. M., Nemunaitis, J.> ;Cancer Gene Ther. 2011 May
Lung cancer vaccines.
Eager, R., Harle, L., Nemunaitis, J. J.> ;Curr Gene Ther. 2007 Dec
Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.
Eager, R. M., Cunningham, C. C., Senzer, N., Richards, D. A., Raju, R. N., Jones, B., Uprichard, M., Nemunaitis, J.> ;Clin Oncol (R Coll Radiol). 2009 Aug 01
Join now to see all

Press Mentions

Ask a Specialist: How Weight Loss Surgery Can Treat Type 2 DiabetesJuly 31st, 2017
Ask a Specialist: Getting in Shape for SummerJune 6th, 2016
“Diabesity” – the Queen’s Medical Center – Ask a SpecialistOctober 26th, 2015

Hospital Affiliations

Virginia Mason Medical CenterSeattle, Washington
St. Francis HospitalFederal Way, Washington

RobertMichaelEagerMD

Dr. Eager is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.